Home LiteratureArticle Details
PMID: 22959562 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

A single-sample microarray normalization method to facilitate personalized-medicine workflows.

Genomics ·Vol. 100 ·No. 6 ·2012-12-00 ·Pages 337-44

Piccolo SR, Sun Y, Campbell JD, Lenburg ME, Bild AH, Johnson WE

Abstract

Gene-expression microarrays allow researchers to characterize biological phenomena in a high-throughput fashion but are subject to technological biases and inevitable variabilities that arise during sample collection and processing. Normalization techniques aim to correct such biases. Most existing methods require multiple samples to be processed in aggregate; consequently, each sample's output is influenced by other samples processed jointly. However, in personalized-medicine workflows, samples may arrive serially, so renormalizing all samples upon each new arrival would be impractical. We have developed Single Channel Array Normalization (SCAN), a single-sample technique that models the effects of probe-nucleotide composition on fluorescence intensity and corrects for such effects, dramatically increasing the signal-to-noise ratio within individual samples while decreasing variation across samples. In various benchmark comparisons, we show that SCAN performs as well as or better than competing methods yet has no dependence on external reference samples and can be applied to any single-channel microarray platform.

MeSH Terms
Analysis of Variance Fluorescence Gene Expression Profiling/methods High-Throughput Screening Assays/methods Humans Oligonucleotide Array Sequence Analysis/methods Precision Medicine/methods Sample Size Selection Bias Signal-To-Noise Ratio Workflow
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Piccolo Stephen R
Department of Pharmacology and Toxicology, University of Utah, 201 Presidents Circle, Salt Lake City, UT 84112, USA.
Sun Ying
Campbell Joshua D
Lenburg Marc E
Bild Andrea H
Johnson W Evan
References (22)
22 references, click to expand
  1. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
    N Engl J Med. 2004 Dec 30;351(27):2817-26 PMID: 15591335
  2. Spatio-temporal transcriptome of the human brain.
    Nature. 2011 Oct 26;478(7370):483-9 PMID: 22031440
  3. Comparative analysis of microarray normalization procedures: effects on reverse engineering gene networks.
    Bioinformatics. 2007 Jul 1;23(13):i282-8 PMID: 17646307
  4. Molecular target class is predictive of in vitro response profile.
    Cancer Res. 2010 May 1;70(9):3677-86 PMID: 20406975
  5. Gene expression profiling predicts clinical outcome of breast cancer.
    Nature. 2002 Jan 31;415(6871):530-6 PMID: 11823860
  6. Exon arrays provide accurate assessments of gene expression.
    Genome Biol. 2007;8(5):R82 PMID: 17504534
  7. Algorithm-driven artifacts in median polish summarization of microarray data.
    BMC Bioinformatics. 2010 Nov 11;11:553 PMID: 21070630
  8. Robust estimators for expression analysis.
    Bioinformatics. 2002 Dec;18(12):1585-92 PMID: 12490442
  9. Linking oncogenic pathways with therapeutic opportunities.
    Nat Rev Cancer. 2006 Sep;6(9):735-41 PMID: 16915294
  10. Model-based analysis of tiling-arrays for ChIP-chip.
    Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12457-62 PMID: 16895995
  11. Frozen robust multiarray analysis (fRMA).
    Biostatistics. 2010 Apr;11(2):242-53 PMID: 20097884
  12. Integrated genomic analyses of ovarian carcinoma.
    Nature. 2011 Jun 29;474(7353):609-15 PMID: 21720365
  13. affy--analysis of Affymetrix GeneChip data at the probe level.
    Bioinformatics. 2004 Feb 12;20(3):307-15 PMID: 14960456
  14. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data.
    Nucleic Acids Res. 2005 Nov 10;33(20):e175 PMID: 16284200
  15. Summaries of Affymetrix GeneChip probe level data.
    Nucleic Acids Res. 2003 Feb 15;31(4):e15 PMID: 12582260
  16. Predicting the clinical status of human breast cancer by using gene expression profiles.
    Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11462-7 PMID: 11562467
  17. A pharmacogenomic method for individualized prediction of drug sensitivity.
    Mol Syst Biol. 2011 Jul 19;7:513 PMID: 21772261
  18. NCBI GEO: archive for functional genomics data sets--10 years on.
    Nucleic Acids Res. 2011 Jan;39(Database issue):D1005-10 PMID: 21097893
  19. Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection.
    J Clin Oncol. 2010 Apr 1;28(10):1671-6 PMID: 20065191
  20. Tackling the widespread and critical impact of batch effects in high-throughput data.
    Nat Rev Genet. 2010 Oct;11(10):733-9 PMID: 20838408
  21. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease.
    Science. 2006 Sep 29;313(5795):1929-35 PMID: 17008526
  22. Genomics and the continuum of cancer care.
    N Engl J Med. 2011 Jan 27;364(4):340-50 PMID: 21268726
Article Info
Journal
Genomics
Abbr.
Genomics
ISSN
1089-8646
Published
2012-12-00
Epub
2012-00-19
Pages
337-44
Language
English
Region
United States
NLM ID
8800135
PMCID
PMC3508193
Subset
IM
Grants
NIGMS NIH HHS · R01 GM085601 · United States
NHGRI NIH HHS · R01 HG005692 · United States
NHGRI NIH HHS · 1R01HG00569 · United States
NCI NIH HHS · T32 CA093247 · United States
NCI NIH HHS · 5T32CA093247 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]